Method of inhibiting secretory effects caused by Cholera

Details Method of inhibiting secretory effects caused by Cholera Method of inhibiting secretory effects caused by Cholera

1997-06-17

1999-07-27

Spivack, Phyllis G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514468, 514420, A61K 3144, A61K 3134, A61K 31405

Patent

active

059290951

ABSTRACT:
The administration of the PAF antagonists BN 52021 and SR 27417, in combination with cyclooxygenase antagonist indomethacin are disclosed as effective in inhibiting the secretory effects caused by Cholera toxin.

REFERENCES:
Van Loon et al., Gut, 33/5, 643-645 (1992).

Affiliated with

Also associated with

Rating

Method of inhibiting secretory effects caused by Cholera does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inhibiting secretory effects caused by Cholera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting secretory effects caused by Cholera will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-879089